Ecopetrol
EC
Lennar Corp
LEN
KB Home
KBH
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
WVE Wave Life Sciences
- 13.160
- -0.320-2.37%
Trading Dec 27 10:18 ET
2.01BMarket Cap-11.75P/E (TTM)
13.540High13.110Low107.67KVolume13.330Open13.480Pre Close1.44MTurnover0.16%Turnover RatioLossP/E (Static)152.52MShares16.73552wk High14.17P/B890.96MFloat Cap3.50052wk Low--Dividend TTM67.70MShs Float56.000Historical High--Div YieldTTM3.19%Amplitude1.160Historical Low13.352Avg Price1Lot Size
Wave Life Sciences Stock Forum
Sign in to post a comment
$Wave Life Sciences (WVE.US)$ news coming out anytime this week 18th/19th/20th dec ...buyout? partnership?
1
$Wave Life Sciences (WVE.US)$ already have terrible earnings 😎
$Wave Life Sciences (WVE.US)$ now they file mixed shelf offering great make it take a dive more stupid 😎
$Wave Life Sciences (WVE.US)$ darn estimate EPS-28 actual EPS-47 terrible bad earnings 😎
$Lightbridge (LTBR.US)$ $Biodexa Pharmaceuticals (BDRX.US)$ $Fangdd Network (DUO.US)$ $Connexa Sports Technologies (YYAI.US)$ $Arqit Quantum (ARQQ.US)$ $SAIHEAT (SAIH.US)$ $Wave Life Sciences (WVE.US)$ $ProQR Therapeutics (PRQR.US)$ $Carmell (CTCX.US)$ $Korro Bio (KRRO.US)$ $Quoin Pharmaceuticals (QNRX.US)$ $Versus Systems (VS.US)$ $Santech Holdings (STEC.US)$ $180 Life Sciences (ATNF.US)$
1
1
$Wave Life Sciences (WVE.US)$
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
1
$Wave Life Sciences (WVE.US)$
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
1
$Wave Life Sciences (WVE.US)$ GSK plc acquires $22.3 million worth of Wave Life Sciences shares
In a notable transaction, GSK (LON:GSK) plc, a major player in the pharmaceutical industry, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million.
This strategic move by GSK plc, which is known for its diverse portfolio of healthca...
In a notable transaction, GSK (LON:GSK) plc, a major player in the pharmaceutical industry, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million.
This strategic move by GSK plc, which is known for its diverse portfolio of healthca...
2
No comment yet
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Allan Wu : Listen to you.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")